The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
10-(3-N-[(b-hydroxyethyl)piperazino]propyl)-2,4-dimethylacridone ID: ALA4086583
PubChem CID: 137645040
Max Phase: Preclinical
Molecular Formula: C24H31N3O2
Molecular Weight: 393.53
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc(C)c2c(c1)c(=O)c1ccccc1n2CCCN1CCN(CCO)CC1
Standard InChI: InChI=1S/C24H31N3O2/c1-18-16-19(2)23-21(17-18)24(29)20-6-3-4-7-22(20)27(23)9-5-8-25-10-12-26(13-11-25)14-15-28/h3-4,6-7,16-17,28H,5,8-15H2,1-2H3
Standard InChI Key: UYAUJRRVENQURC-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
24.4988 -2.7694 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.4988 -1.1350 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.2040 -1.5477 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.2024 -2.3631 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9067 -2.7704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6129 -2.3634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6106 -1.5449 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9058 -1.1413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7935 -2.3649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7960 -1.5495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0923 -1.1414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3855 -1.5476 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3869 -2.3661 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0912 -2.7705 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4973 -0.3178 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.9060 -3.5876 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.3170 -1.1341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4999 -3.5866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7928 -3.9962 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7940 -4.8134 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0869 -5.2230 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.3803 -4.8152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6753 -5.2213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6722 -6.0388 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.3804 -6.4486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0916 -6.0408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9636 -6.4458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2568 -6.0356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5482 -6.4425 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10 2 1 0
9 1 1 0
1 4 1 0
3 2 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 3 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
2 15 2 0
5 16 1 0
7 17 1 0
1 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
21 26 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
24 27 1 0
27 28 1 0
28 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 393.53Molecular Weight (Monoisotopic): 393.2416AlogP: 2.77#Rotatable Bonds: 6Polar Surface Area: 48.71Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 7.78CX LogP: 3.39CX LogD: 2.85Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.65Np Likeness Score: -0.73
References 1. Murahari M, Kharkar PS, Lonikar N, Mayur YC.. (2017) Design, synthesis, biological evaluation, molecular docking and QSAR studies of 2,4-dimethylacridones as anticancer agents., 130 [PMID:28246041 ] [10.1016/j.ejmech.2017.02.022 ]